News - Media

Drs. Sayuri Suzuki, Andrea Fleig, and colleagues identify the bioactive sites on waixenicin A that inhibit the TRPM7 channel. The manuscript has been published in the Journal of Natural Products.

In this study, Drs. Suzuki and Fleig collaborated with a multi-disciplinary of chemists and physiologists to characterize the structure-activity relationships of waixenicin A, a xenicane diterpene from the Hawaiian coral Sarcothelia edmondsoni. Waixenicin A is a selective and potent inhibitor of the TRPM7 ion channel, which is

Read More »

Congratulations to Dr. Michael A. Ortega for being awarded an R21 grant through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH)! Dr. Ortega’s lab is based out of the Queen’s Medical Center for Biomedical Research (QCBR), where his team investigates mechanisms of kidney injury response.

The grant titled “TWEAK-Fn14 regulation of non-canonical NF-κB signaling in chronic renal inflammation,” will support the Ortega Lab for 3 years as the team focuses

Read More »